STAT3 and cancer: This complex interplay of epigenetic and transcriptional regulation highlights the central role of TKT in cancer metabolism, suggesting its potential as a therapeutic target, particularly in terms of inhibiting the STAT3-TKT signaling pathway and regulating TKT expression.